Polymer-based Drug Delivery

Bayer Schering Pharma Oy is the center of excellence in polymer technology within the Group. We master the entire development chain from research to manufacturing and marketing. By increasing patient compliance, our innovative long-acting drug delivery systems and products can overcome the compliance issues faced in chronic therapy, thereby maximizing the preventive and therapeutic efficacy of medications for the benefit of patients.

Bayer Schering Pharma Oy’s polymer-based drug delivery technology can be used to develop products for drug therapies that require continuous and constant drug delivery and last from a few months to several years. The hormone therapy and contraceptive products manufactured on the basis of the polymer-based drug delivery technology of Bayer Schering Pharma Oy are pioneers around the world. Today, several millions of users in about 100 countries benefit from this technology. The best known of these products is MIRENA®, the hormonal intrauterine contraceptive system with a 5-year efficacy.